The team at Seaport Therapeutics, a Boston neuropsychiatry biotech, is having a good fall season.
Seaport said Monday it has pieced together $225 million from …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Merck filed the application based on findings from the Phase III LITESPARK-005 trial in advanced renal cell carcinoma patients. Credit: Jo Panuwat D/Shutterstock.com. The US
President Joe Biden is working to lay out his health agenda for a second term, even as Congress races to finish its overdue spending bills
Mouth closure during sleep worsened airflow in some patients with obstructive sleep apnea (OSA), according to a study that cast doubt on a viral trend